PF-AtlasClinical Trials › NCT07820254

Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients

Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients · Not specified

Registry ID
NCT07820254
Phase
Not specified
Status
Recruiting
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Enrollment
60
Locations
1

About this trial

The goal of this observational study is to learn about the inspiratory flow rate capability in patients with pulmonary fibrosis (IPF or PPF) when using inhaler devices with different resistances. The main questions it aims to answer are: What is the peak inspiratory flow rate (PIFR) that patients with pulmonary fibrosis can achieve through a medium-resistance inhaler device? What is the peak inspiratory flow rate (PIFR) that patients with pulmonary fibrosis can achieve through a high-resistance inhaler device? What is the inspiratory time (EIT) for each resistance level? Participants will use a portable device called In-Check™ DIAL G16, which simulates the resistance of different dry powder inhalers. Each participant will perform two breathing tests at a medium-resistance setting and t

View NCT07820254 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07820254 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.